WO1980000007A1 - Medical sleeve - Google Patents

Medical sleeve Download PDF

Info

Publication number
WO1980000007A1
WO1980000007A1 PCT/US1979/000354 US7900354W WO8000007A1 WO 1980000007 A1 WO1980000007 A1 WO 1980000007A1 US 7900354 W US7900354 W US 7900354W WO 8000007 A1 WO8000007 A1 WO 8000007A1
Authority
WO
WIPO (PCT)
Prior art keywords
sleeve
vessel
set forth
sheath
medical device
Prior art date
Application number
PCT/US1979/000354
Other languages
French (fr)
Inventor
A Rockey
Original Assignee
A Rockey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25431251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1980000007(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A Rockey filed Critical A Rockey
Publication of WO1980000007A1 publication Critical patent/WO1980000007A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/0076Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/003Implantable devices or invasive measures inflatable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/0036Intragastrical devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1002Balloon catheters characterised by balloon shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/061Blood vessels provided with means for allowing access to secondary lumens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/10Trunk
    • A61M2210/1042Alimentary tract
    • A61M2210/1053Stomach

Definitions

  • a gastric bypass may be accomplished by anastomosing a minor portion of the stomach to the jejunum while leaving the major portion connected to the duodenum.
  • an intestinal bypass involves the short-circuiting of a majority of the combined lengths of the jejunum and ileu by connecting the first part of the jejunum to the last part of the ileum.
  • O PI Beyond statistically significant operative and overall mortality rates, reported complications following the gastri bypass include marginal ulcers and wound infections.
  • the intestinal bypass involves similar mortality rates and, reportedly, a greater number of postoperative complications and side effects. These include pulmonary emboli, wound infections, gastrointestinal hemorrhage, renal failure, and numerous other disorders. The nature, severity, and fre ⁇ quency of these problems have in fact led to doubts as to th advisability of the techniques for treatment of obesity.
  • the invention provides a method and means for iso ⁇ lating the internal walls of hollow viscera or other body vessels from contact with materials, both fluids and solids, occurring naturally, ingested, or otherwise introduced into body vessel.
  • Isolation of a body vessel is achieved by positioning and anchoring a sleeve, impervious to materials sought to be isolated within the ves sel, in such a manner that the sleeve, at least adjacent its upstream end, is in sealing engagement with the surrounding interior tissue of the vessel. Material otherwise normally flowing into the vessel and being capable of interracting with the vessel to the detriment of the patient's health is thereby contained and rendered ineffectual on or unaffected by the vessel.
  • a sleeve impervious to both gastr ⁇ secretions and food substances is disposed within the stomach in a manner which prevents contact between these gastric se ⁇ cretions and food substances. More specifically, the sleeve acts as a liner for at least a portion of the internal stom ⁇ ach area while also providing a conduit for food passing through the stomach.
  • the sleeve which is capable of estab ⁇ lishing a circumferential, substantially fluid-tight seal with the walls of the stomach adjacent its upstream end, may be any desired length so that a suitable portion of the in ⁇ ternal stomach area is rendered ineffectual in the digestive process. Consequently, the sleeve is operative to limit the efficienc of food absorption in the small intestine.
  • the sleeve may be introduced into the stomach through the oral cavity and esophagus.
  • the sleeve is sufficiently flexible to be collapsed into a unit of relatively low bulk for ease of passage through the posterior pharynx and esophagus.
  • the sleeve is expanded by means carried with the sleeve, including a flexi ⁇ ble tube trailing the sleeve.
  • a source of pressurized fluid external of the patient's body is operably connected to the expanding means through this trailing tube to expand the sleeve into sealing engagement with the walls of the stom ⁇ ach.
  • the sleeve may be additionally restrained against further movement along the digestive tract by anchoring the trailing tube or a separate parallel element upstream in the digestive tract.
  • the tissue isolating function of the disclosed sleeve in addition to control of the mechanism of digestion, has numerous other applications in diagnosis or treatment of body disorders.
  • the sleeve may be used to chem ⁇ ically and/or physically protect tissue which has been ulcer ⁇ ated, herniated, fissured, or the like from natural body fluids. Ruptured blood vessels or aneurysms may be protected from further damage and allowed to heal by isolating the ef ⁇ fect of normal blood pressure from the vessel by containing it within the sleeve.
  • Stenosis or a sclerotic closing of an artery may be expanded from within by the use of internal compression while still allowing blood to pass through, especially in those individuals whose disease is so far advanced that a graft could not be sutured to the distal portion of *the vessel.
  • one or more tubes connected to the sleeve may be arranged to provide communication between the annular zone intermediate the protected vessel and the outer surface of the sleeve for introduction of medicines or aspiration of fluids from the zone.
  • FIG. 1 is a perspective view of a vessel-insertable medical sleeve unit constructed in accordance with the inven ⁇ tion;
  • FIG. 2 is a fragmentary, cross sectional view on an enlarged scale through the wall of the sleeve unit, taken along the line 2-2 of FIG. 1;
  • FIG. 2a is a fragmentary, cross sectional view simi ⁇ lar to FIG. 3, taken along the line 2 -2_ of FIG. 1;
  • FIG. 3 is a fragmentary, cross sectional view on an enlarged scale, taken along the line 3-3 of FIG. 1 of a trailing filament of the sleeve unit;
  • FIG. 4 is a schematic illustration of a manner of use of the sleeve to control obesity;
  • FIG. 5 is a view of the sleeve unit in a compacted condition and contained within a dialator shell for instal ⁇ lation;
  • FIG. 6 is a view of the sleeve unit depicting an intermediate configuration in a progressive sequence of expansion from the condition of FIG. 4;
  • FIG. 7 is a view of the sleeve progressed in its transition from FIG. 5 through FIG. 6 to a fully expanded configuration essentially corresponding, to FIG. 4;
  • FIG. 8 is a schematic view of a second embodiment of the sleeve of the invention employed within an aorta.
  • a sleeve unit 10 in the form of a cylindrical, tubular sheath 11 and one or more inflator ring balloons 12-14.
  • the sheath 11 in the illustrated example is a flexible membrane of nontoxic material impervious and chem ⁇ ically resistant to body fluids which it is expected to en ⁇ counter.
  • the sheath material is selected from a variety of known plastic and/or elastomeric substances.
  • the sheath 11 may be extruded, rolled, or otherwise formed, as desired, into a tube with or without a longitudinal seam or seams.
  • the inflator ring balloons 12-14 as indicated in FIG. 1 are flexible, hollow, torroid-like elements spaced axially along the interior of the sheath 11. As indicated, the rings 12 and 14 are adjacent opposite ends 16 and 17 of the sheath 11.
  • the ring balloons 12-14 may be formed of a material the same as or like that of the sheath 11, and are either integrally formed thereon or are bonded thereto by heat, adhesive, solvent or like means. While the sheath 11 is illustrated as a cylinder, it will be understood that it may take other configurations, such as a frustum or a sphere truncated adjacent opposite poles, or a tubular elbow of con stant or varying diameter.
  • the sleeve unit 10 includes at least one, and preferably two, trailing hollow filaments 20,21 connected thereto by bonding or other suitable means. These filaments 20,21 may be made of the same or similar material as the sheath 11.
  • each of the filaments 20-21 includes a central lumen 22 and an auxil obviouslyy lumen 23. When desired or necessary, additional lumens may be disposed in the wall of each filament 20-21.
  • one of the filaments 20 has its central lumen 22 in fluid communication with an upstream one 12 of the ring balloons, while the other filament 21 has its central lumen 22 in flui communication with the remaining ring balloons 13 and 14.
  • longitudinally spaced, gen ⁇ erally radial passages 26 provide communication from the auxiliary lumens 23 of each filament 20, 21 through the adjacent wall of the sheath 11 to points external of the sleeve unit 10.
  • the exterior surface of the filaments 20,21 and internal surface of the sheath 11 are sealed to one another by suitable means, such as bonding or the like, at their points of tangency so that fluids in the auxiliary lumens cannot escape into the interior, designated 27, of th sheath 11 at the radial passages or apertures 26.
  • the sleeve unit 10 is implanted in a body vessel in order to isolate the walls of such vessel from fluids normal ⁇ ly flowing into it.
  • FIG. 4 illustrates a manner of use of the sleeve unit 10 to isolate the internal surface area or lumen, designated 31, of a human stomach 32 and its secre ⁇ tions from food substances passing through it.
  • the sleeve unit 10 is implanted in the stomach 32 in a nonsurgical man ⁇ ner by passing it through an oral cavity 33, pharynx 34, and esophagus 35.
  • the sleeve unit is folded on itself accordion fashion to reduce its length and diameter. In its folded or compacted state, the sleeve unit 10 is contained within a dialator shell or cup 37 (Figs. 5 and 6) .
  • the dialator shell 37 has .a rounded profile for ease of passage through the natural lumen of the digestive tract, generally indicated at 39 (FIG. 4).
  • the dialator shell 37 carrying the collapsed sleeve unit 10 is inserted through the epiglotis, whereupon natural- swallowing action allows it to be readily " advanced into the stomach 32.
  • FIG. 6 depicts this action, wherein the dialator shell 37 is released from the sleeve unit 10 and allowed to pass through the lower portion of the digestive tract 39.
  • the sleeve unit 10 in a continuous sequence of movement expands from the intermediate position of FIG. 6 to that of FIG. 7.
  • the final position of the sleeve unit 10 in the stomach 32 may be adjusted by pumping fluid through the auxiliary lumens 23 in such a manner that it issues passages 26 as a jet developing a reaction force to shift the adjacent area of the sleeve unit in one direction or another, depending on the orientation of the passages.
  • These passages 26 may be provided with either an axial or tangential compo ⁇ nent in their orientation with respect to the axial direction of the sleeve to cause corresponding axial or turning move ⁇ ment of the sleeve.
  • the sleeve unit 10 includ ⁇ ing the filaments 20, 21 and ring balloons 12-14, is provided with sufficient radiopaque material to permit external obser ⁇ vation of its position and configuration.
  • the ring balloons 12-14 are finally inflated through the central filament lumens 22, again by a source of pressurized fluid external of the patient's body. Inflation of the ring balloons 12-14 causes them, in the manner of circumferential stiffening ribs, to fully expand the sleeve into tight sealing engage ⁇ ment with the interior surface 31 of the stomach vessel 32.
  • the ends of the filaments 20, " 21 ⁇ distal from the ⁇ sle ⁇ eve ⁇ unit 10 are anchored to a posterior tooth or prosthesis by suit ⁇ able fastening means or are sutured in place.
  • the central or main lumens 22 of the filaments 20,21 are closed at these anchoring points by heat sealing, plugging, or the like, to indefinitely maintain a pressurized state in the connected ring balloons 12-14 to keep the adjacent sleeve areas in fluid-tight engagement with the stomach wall 31.
  • the middle and lower ring balloons 13, 14 may be intermittently or permanently depressurized so that these fluids may pass through the remainder of the digestive tract.
  • fluids secreted by the stomach area 31 shielded by the sleeve unit 10 may be aspirated through the oral cavity by way of the auxiliary lumens 23 and passages 26.
  • medicine may be carried into the annular zone defined between the sheath 11 and stomach waTTp 31 through the oral cavity by way of the auxiliary lumens 23 and passages 26.
  • the sleeve unit 10 by isolating the walls 31 of the stomach 32 from ingested food passing through it, reduces the digestive efficiency of the stomach. This results from interference with the normal contact of gastric juices, secreted by the stomach walls 31, on such food and the inability of the intestines of the lower digestive tract to absorb undigested food.
  • the patient while consuming food in even large quantities, is enabled to lose weight, since only a limited amount of the ingested food is ultimate ⁇ ly absorbed.
  • the sleeve 10 may be disposed in the small intestine, rather than in the stomach, to directly reduce the effective area of the intestine available for absorption, again for the control of obesity.
  • the sleeve may be utilized to medicate an ulcerous zone and isolate it from gastric juices to hasten normal recovery.
  • FIG. 8 there is shown a second embodiment of the invention wherein a sleeve 25 is disposed within a human aorta 30 and associated right and left common iliac arteries 31, 32.
  • the sleeve 25 is bifurcated at one end to provide a pair of branches 25a and 25b corresponding to the right and left common iliac arteries 31, 32 respec ⁇ tively.
  • the sleeve 25 has a construction essentially the same as the earlier-described sleeve 10.
  • Ring balloons 33 are spaced axially along the sleeve including the branch portions 25a,25b. Each of the ring balloons 33 is in fluid communication with at least one hollow filament 34,35 for purposes of inflation.
  • the sleeve 25 is advantageously employed in cases o advanced blood vessel disease where a patient's tissue is such that it is impossible to sew or anastomose it with grafts or artificial vessels.
  • An incision 41 is made in the vessel 30 to allow the positioning of the sleeve 25 therein.
  • the sleeve 25 is expanded into position by directing fluid pressure into the elongated filaments 34,35 in any suitable manner such as disclosed above with use of free extensions (not shown) of these filaments.
  • the sleeve 25 is anchored in the vessel 30, for example, by sutures 42 near the incision 41, while the dista portion of the sleeve remains free.
  • One or more holes 43 may be cut into the wall of the sleeve prior to placement within the vessel to provide blood flow to various arterial branches 46.
  • the sleeve 25 is preferably formed of relatively inelas ⁇ tic material or otherwise is circumferentially reinforced with inelastic material along its length so that the pressure of blood flowing through the_ sleeve is_ effectively isolated from the vessel 30.

Abstract

A method and article for medical diagnosis and/or treatment of body disorders, comprising a sleeve unit (10) insertable in a natural body vessel to isolate material flowing into the vessel from direct contact with the interior surface of the vessel. When applied to the treatment of obesity, the sleeve is disposed along a zone in the digestive tract (32) to interfere with the digestive or absorptive function of that zone and thereby reduce net caloric intake.

Description

MEDICAL SLEEVE
BACKGROUND OF THE INVENTION
In the diagnosis and/or treatment of disorders of the body, it is known to physically alter the condition or function of hollow viscera or other internal body vessels. Surgical procedures on such vessels include reconstruction of natural tissue, substitution and bypass techniques with natural or artificial implants. Surgery is recognized as always carrying some degree of risk to the patient, both dur¬ ing its actual performance and in postoperative complications or side effects. These risks, of course, are of major con¬ cern when the surgery involves the invasion of the great cavity of the trunk of the human body. This is especially true in treatment of such viscera as the heart, liver, or intestines, and in particular when such surgery involves these organs themselves.
In surgical treatment of obesity, for example, the abdominal cavity is exposed to allow reconstruction of the digestive tract, in essence, to reduce the internal surface area available for food digestion or absorption of digested substances. The former technique, a gastric bypass, may be accomplished by anastomosing a minor portion of the stomach to the jejunum while leaving the major portion connected to the duodenum. The latter of these techniques, an intestinal bypass, involves the short-circuiting of a majority of the combined lengths of the jejunum and ileu by connecting the first part of the jejunum to the last part of the ileum.
Both of these operations are deemed to involve such high risk to the patient that they are considered only as a lifesaving undertaking for morbidly obese individuals.
O PI Beyond statistically significant operative and overall mortality rates, reported complications following the gastri bypass include marginal ulcers and wound infections. The intestinal bypass involves similar mortality rates and, reportedly, a greater number of postoperative complications and side effects. These include pulmonary emboli, wound infections, gastrointestinal hemorrhage, renal failure, and numerous other disorders. The nature, severity, and fre¬ quency of these problems have in fact led to doubts as to th advisability of the techniques for treatment of obesity.
SUMMARY OF THE INVENTION
The invention provides a method and means for iso¬ lating the internal walls of hollow viscera or other body vessels from contact with materials, both fluids and solids, occurring naturally, ingested, or otherwise introduced into body vessel. Isolation of a body vessel, according to the invention, is achieved by positioning and anchoring a sleeve, impervious to materials sought to be isolated within the ves sel, in such a manner that the sleeve, at least adjacent its upstream end, is in sealing engagement with the surrounding interior tissue of the vessel. Material otherwise normally flowing into the vessel and being capable of interracting with the vessel to the detriment of the patient's health is thereby contained and rendered ineffectual on or unaffected by the vessel.
An important application of the invention is the nonsurgical treatment of obesity through reduction in the effective natural surface area of the digestive tract. In one disclosed embodiment, a sleeve impervious to both gastr^ secretions and food substances is disposed within the stomach in a manner which prevents contact between these gastric se¬ cretions and food substances. More specifically, the sleeve acts as a liner for at least a portion of the internal stom¬ ach area while also providing a conduit for food passing through the stomach. The sleeve, which is capable of estab¬ lishing a circumferential, substantially fluid-tight seal with the walls of the stomach adjacent its upstream end, may be any desired length so that a suitable portion of the in¬ ternal stomach area is rendered ineffectual in the digestive process. Consequently, the sleeve is operative to limit the efficienc of food absorption in the small intestine.
As disclosed, the sleeve may be introduced into the stomach through the oral cavity and esophagus. In the pre¬ ferred embodiment, the sleeve is sufficiently flexible to be collapsed into a unit of relatively low bulk for ease of passage through the posterior pharynx and esophagus. Upon reaching a desired position in the stomach, the sleeve is expanded by means carried with the sleeve, including a flexi¬ ble tube trailing the sleeve. A source of pressurized fluid external of the patient's body is operably connected to the expanding means through this trailing tube to expand the sleeve into sealing engagement with the walls of the stom¬ ach. The sleeve may be additionally restrained against further movement along the digestive tract by anchoring the trailing tube or a separate parallel element upstream in the digestive tract.
The tissue isolating function of the disclosed sleeve, in addition to control of the mechanism of digestion, has numerous other applications in diagnosis or treatment of body disorders. For example, the sleeve may be used to chem¬ ically and/or physically protect tissue which has been ulcer¬ ated, herniated, fissured, or the like from natural body fluids. Ruptured blood vessels or aneurysms may be protected from further damage and allowed to heal by isolating the ef¬ fect of normal blood pressure from the vessel by containing it within the sleeve.
Stenosis or a sclerotic closing of an artery may be expanded from within by the use of internal compression while still allowing blood to pass through, especially in those individuals whose disease is so far advanced that a graft could not be sutured to the distal portion of *the vessel. Still further, where desired, one or more tubes connected to the sleeve may be arranged to provide communication between the annular zone intermediate the protected vessel and the outer surface of the sleeve for introduction of medicines or aspiration of fluids from the zone.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a perspective view of a vessel-insertable medical sleeve unit constructed in accordance with the inven¬ tion;
FIG. 2 is a fragmentary, cross sectional view on an enlarged scale through the wall of the sleeve unit, taken along the line 2-2 of FIG. 1;
FIG. 2a is a fragmentary, cross sectional view simi¬ lar to FIG. 3, taken along the line 2 -2_ of FIG. 1;
FIG. 3 is a fragmentary, cross sectional view on an enlarged scale, taken along the line 3-3 of FIG. 1 of a trailing filament of the sleeve unit; FIG. 4 is a schematic illustration of a manner of use of the sleeve to control obesity;
FIG. 5 is a view of the sleeve unit in a compacted condition and contained within a dialator shell for instal¬ lation;
FIG. 6 is a view of the sleeve unit depicting an intermediate configuration in a progressive sequence of expansion from the condition of FIG. 4;
FIG. 7 is a view of the sleeve progressed in its transition from FIG. 5 through FIG. 6 to a fully expanded configuration essentially corresponding, to FIG. 4; and
FIG. 8 is a schematic view of a second embodiment of the sleeve of the invention employed within an aorta.
DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring now to the drawings, and in particular to FIG. 1, there is shown a sleeve unit 10 in the form of a cylindrical, tubular sheath 11 and one or more inflator ring balloons 12-14. The sheath 11 in the illustrated example is a flexible membrane of nontoxic material impervious and chem¬ ically resistant to body fluids which it is expected to en¬ counter. The sheath material is selected from a variety of known plastic and/or elastomeric substances. The sheath 11 may be extruded, rolled, or otherwise formed, as desired, into a tube with or without a longitudinal seam or seams.
O PI 1P0 - The inflator ring balloons 12-14 as indicated in FIG. 1 are flexible, hollow, torroid-like elements spaced axially along the interior of the sheath 11. As indicated, the rings 12 and 14 are adjacent opposite ends 16 and 17 of the sheath 11. The ring balloons 12-14 may be formed of a material the same as or like that of the sheath 11, and are either integrally formed thereon or are bonded thereto by heat, adhesive, solvent or like means. While the sheath 11 is illustrated as a cylinder, it will be understood that it may take other configurations, such as a frustum or a sphere truncated adjacent opposite poles, or a tubular elbow of con stant or varying diameter. The sleeve unit 10 includes at least one, and preferably two, trailing hollow filaments 20,21 connected thereto by bonding or other suitable means. These filaments 20,21 may be made of the same or similar material as the sheath 11. In the illustrated case, each of the filaments 20-21 includes a central lumen 22 and an auxil iary lumen 23. When desired or necessary, additional lumens may be disposed in the wall of each filament 20-21. Ideally one of the filaments 20 has its central lumen 22 in fluid communication with an upstream one 12 of the ring balloons, while the other filament 21 has its central lumen 22 in flui communication with the remaining ring balloons 13 and 14.
As suggested in FIG. 3, longitudinally spaced, gen¬ erally radial passages 26 provide communication from the auxiliary lumens 23 of each filament 20, 21 through the adjacent wall of the sheath 11 to points external of the sleeve unit 10. The exterior surface of the filaments 20,21 and internal surface of the sheath 11 are sealed to one another by suitable means, such as bonding or the like, at their points of tangency so that fluids in the auxiliary lumens cannot escape into the interior, designated 27, of th sheath 11 at the radial passages or apertures 26. The sleeve unit 10 is implanted in a body vessel in order to isolate the walls of such vessel from fluids normal¬ ly flowing into it. FIG. 4 illustrates a manner of use of the sleeve unit 10 to isolate the internal surface area or lumen, designated 31, of a human stomach 32 and its secre¬ tions from food substances passing through it. The sleeve unit 10 is implanted in the stomach 32 in a nonsurgical man¬ ner by passing it through an oral cavity 33, pharynx 34, and esophagus 35. To facilitate introduction of the sleeve unit 10 into the stomach 32, the sleeve unit is folded on itself accordion fashion to reduce its length and diameter. In its folded or compacted state, the sleeve unit 10 is contained within a dialator shell or cup 37 (Figs. 5 and 6) . The dialator shell 37 has .a rounded profile for ease of passage through the natural lumen of the digestive tract, generally indicated at 39 (FIG. 4). The dialator shell 37 carrying the collapsed sleeve unit 10 is inserted through the epiglotis, whereupon natural- swallowing action allows it to be readily" advanced into the stomach 32.
Upon reaching the stomach 32, one or both of the central lumens 22 of the filaments 20,21 are connected to a source of pressurized fluid, such as air, ordinarily external of the oral cavity 33. Lower sections of the filaments 20, 21 longitu inally associated with the sheath 11 develop forces upon pressurization, tending to unfold themselves along with the sheath. FIG. 6 depicts this action, wherein the dialator shell 37 is released from the sleeve unit 10 and allowed to pass through the lower portion of the digestive tract 39. The sleeve unit 10 in a continuous sequence of movement expands from the intermediate position of FIG. 6 to that of FIG. 7.
The final position of the sleeve unit 10 in the stomach 32 may be adjusted by pumping fluid through the auxiliary lumens 23 in such a manner that it issues passages 26 as a jet developing a reaction force to shift the adjacent area of the sleeve unit in one direction or another, depending on the orientation of the passages. These passages 26 may be provided with either an axial or tangential compo¬ nent in their orientation with respect to the axial direction of the sleeve to cause corresponding axial or turning move¬ ment of the sleeve. Preferably, the sleeve unit 10, includ¬ ing the filaments 20, 21 and ring balloons 12-14, is provided with sufficient radiopaque material to permit external obser¬ vation of its position and configuration. When the position of the sleeve unit 10 is satisfactory, the ring balloons 12-14 are finally inflated through the central filament lumens 22, again by a source of pressurized fluid external of the patient's body. Inflation of the ring balloons 12-14 causes them, in the manner of circumferential stiffening ribs, to fully expand the sleeve into tight sealing engage¬ ment with the interior surface 31 of the stomach vessel 32. The ends of the filaments 20,"21~distal from the ~sle~eve~ unit 10 are anchored to a posterior tooth or prosthesis by suit¬ able fastening means or are sutured in place. The central or main lumens 22 of the filaments 20,21 are closed at these anchoring points by heat sealing, plugging, or the like, to indefinitely maintain a pressurized state in the connected ring balloons 12-14 to keep the adjacent sleeve areas in fluid-tight engagement with the stomach wall 31. Where desired, for example, to release fluids secreted by the stomach walls 31, the middle and lower ring balloons 13, 14 may be intermittently or permanently depressurized so that these fluids may pass through the remainder of the digestive tract. Alternatively, fluids secreted by the stomach area 31 shielded by the sleeve unit 10 may be aspirated through the oral cavity by way of the auxiliary lumens 23 and passages 26. Moreover, if desired, medicine may be carried into the annular zone defined between the sheath 11 and stomach waTTp 31 through the oral cavity by way of the auxiliary lumens 23 and passages 26.
The sleeve unit 10, by isolating the walls 31 of the stomach 32 from ingested food passing through it, reduces the digestive efficiency of the stomach. This results from interference with the normal contact of gastric juices, secreted by the stomach walls 31, on such food and the inability of the intestines of the lower digestive tract to absorb undigested food. Thus, the patient, while consuming food in even large quantities, is enabled to lose weight, since only a limited amount of the ingested food is ultimate¬ ly absorbed.
Various other uses of the disclosed sleeve 10 or its equivalents are contemplated in the treatment of body disor¬ ders. For instance, the sleeve 10 may be disposed in the small intestine, rather than in the stomach, to directly reduce the effective area of the intestine available for absorption, again for the control of obesity. When disposed in the stomach, the sleeve may be utilized to medicate an ulcerous zone and isolate it from gastric juices to hasten normal recovery.
Referring now to FIG. 8, there is shown a second embodiment of the invention wherein a sleeve 25 is disposed within a human aorta 30 and associated right and left common iliac arteries 31, 32. The sleeve 25 is bifurcated at one end to provide a pair of branches 25a and 25b corresponding to the right and left common iliac arteries 31, 32 respec¬ tively. The sleeve 25 has a construction essentially the same as the earlier-described sleeve 10. Ring balloons 33 are spaced axially along the sleeve including the branch portions 25a,25b. Each of the ring balloons 33 is in fluid communication with at least one hollow filament 34,35 for purposes of inflation. The sleeve 25 is advantageously employed in cases o advanced blood vessel disease where a patient's tissue is such that it is impossible to sew or anastomose it with grafts or artificial vessels. An incision 41 is made in the vessel 30 to allow the positioning of the sleeve 25 therein. The sleeve 25 is expanded into position by directing fluid pressure into the elongated filaments 34,35 in any suitable manner such as disclosed above with use of free extensions (not shown) of these filaments.
The sleeve 25 is anchored in the vessel 30, for example, by sutures 42 near the incision 41, while the dista portion of the sleeve remains free. One or more holes 43 ma be cut into the wall of the sleeve prior to placement within the vessel to provide blood flow to various arterial branches 46. The sleeve 25 is preferably formed of relatively inelas¬ tic material or otherwise is circumferentially reinforced with inelastic material along its length so that the pressure of blood flowing through the_ sleeve is_ effectively isolated from the vessel 30.
The invention is not restricted to the slavish imi¬ tation of each and every detail set forth above. Obviously, devices may be provided which change, eliminate, or add cer¬ tain specific details without departing from the scope of the invention.

Claims

WHAT IS CLAIMED IS:
1. A medical device for treatment of body disor¬ ders, comprising a tubular sleeve adapted to isolate the inner walls of a hollow body vessel from material flowing into the vessel, said sleeve being formed of a material which is impervious, nontoxic, and resistant to attack by antici¬ pated body chemicals and medicines, said sleeve being suffi¬ ciently flexible to be folded on itself to thereby reduce its bulk from a normal configuration to a compacted configuration to facilitate initial placement of the sleeve into the body vessel.
2. A medical device as set forth in claim 1, wherein said sleeve includes means for remotely controlling transition of said sleeve from said compacted configuration to said normal configuration.
3. A medical device for the treatment of body dis¬ orders comprising a tubular sleeve adapted to isolate the inner walls of a hollow body vessel from material flowing into the vessel, said sleeve being formed of a material which is impervious, nontoxic, and resistant to attack by antici¬ pated body chemicals and medicines, said sleeve being formed of a relatively flexible sheath having at least one circum¬ ferential stiffening rib thereon, said circumferential stiff¬ ening rib being adapted to hold said sleeve in fluid-tight engagement with the interior walls of the body vessel.
4. A medical device as set forth in claim 3, where¬ in said circumferential stiffening tube is inflatable to control its stiffness.
5. A medical device as set forth in claim 4, where¬ in said rib is a hollow, torroidal ring, at least one trail¬ ing tube having a lumen in communication with the hollow interior of said rib to permit remote inflation of said rib.
6. A medical device as set forth in claim 5, including means for anchoring said sleeve in said vessel at a point in a body remote from said sleeve.
7. A medical device for treatment of body disorders comprising a tubular sleeve adapted to isolate the interior walls of a hollow body vessel from material flowing into the vessel, said sleeve being formed of material which is imper¬ vious, nontoxic, and resistant to attack by anticipated body chemicals and medicines, said sleeve being sufficiently flexible to be folded on itself to reduce its bulk for implantation in said vessel through a natural body lumen leading to the site of said interior vessel walls, at least one ring balloon extending circumferentially on said sheath, said ring balloon having the configuration of a hollow torroid and being inflatable to radially extend said sheath, elongated hollow filament means connected to said sheath, a lumen in said filament means being in communication with the interior of said ring balloon to permit said ring balloon to be pressurized from a point remote from said sleeve.
8. A medical device as set forth in claim 7, where¬ in said sleeve includes a hollow filament portion extending axially along the sleeve, said filament portion being adapted to be remotely pressurized and, upon pressurization, being arranged to axially extend said sleeve.
9. A medical device as set forth in claim 7, where¬ in said sleeve includes a ring balloon adjacent each end thereof, said ring balloons being inflatable through said hollow filament means to seal each end of said sleeve to the interior walls of said body vessel to thereby define an annu¬ lar zone between said sleeve and the interior walls of said body vessel.
10. A medical device as set forth in claim 7, wherein said sleeve is provided with generally radial passage means therethrough, and means including an elongated lumen connected to said passage means to provide communication between an annular zone between said sleeve and said body vessel and a point remote from said sleeve.
11. A medical device as set forth in claim 10, wherein said passage means is arranged to form a reaction jet when fluid is pumped through said elongated lumen to position said sleeve in said body vessel.
12. A medical device as set forth in claim 7, including a dialator shell having a cavity for receiving the sleeve when it is in a folded condition and having a rounded forward end portion for facilitating movement thereof throug said body vessel.
13. A medical device as set forth in claim 12, wherein said shell is arranged to be ejected from said sleev when said filament means is pressurized and said sleeve is expanded by said ring balloon.
14. _A method of isolating a hallow body vessel fro fluid passing into it, comprising the steps of passing an impervious sheath axially into the vessel through its natura lumen, aligning an end opening of the sheath axially with an upstream end of the zone of the- vessel sought to be isolated and expanding said open end radially into circumferential sealing engagement with the interior walls of the body vesse
15. A method as set forth in claim 14, wherein sai sheath is expanded into sealing engagement with the interior walls of said vessel by means remote from said zone, said remote expanding means being in communication with said sheath through a natural body lumen connected with said vessel.
OM W1
16. A method as set forth in claim 15, wherein said sleeve is provided with inflatable means operative upon inflation to expand said sheath into sealing engagement with the walls of said vessel, and inflating said inflatable means through an artificial lumen extending through said natural body lumen to said remote means.
17. A method as set forth in claim 16, wherein said inflatable means is arranged circumferentially about said sheath such that inflation thereof causes radial extension of said sheath.
18. A method as set forth in claim 17, wherein said inflatable means is arranged axially of said sheath such that inflation thereof causes axial extension of said sheath.
19. A method of controlling obesity, comprising the steps of positioning a sleeve impervious to digestive juices and normal foods in the digestive tract, arranging the sleeve in the digestive tract in such a manner that food material passing through the digestive tract is caused to pass through the sleeve while being isolated from direct contact with the surrounding area of the interior walls of the digestive tract and body fluids secreted by such surrounding area interior walls such that natural absorption of food material in the digestive tract is impaired and a net caloric intake for a given quantity of ingested food is thereby reduced.
20. A method as set forth in claim 19, wherein sa sleeve is disposed in the stomach.
21. A method as set forth in claim 19, wherein sa sleeve is anchored in position in said digestive tract by means extending through the digestive tract to the oral cavity.
22. A method as set forth in claim 19, wherein sa sleeve is positioned in said digestive tract through the or cavity.
23. A method as set forth in claim 22, wherein sa sleeve is passed through the oral cavity and other upper areas of the digestive tract in a compacted condition and i expanded into sealing contact with at least a portion of sa surrounding area of said interior walls.
PCT/US1979/000354 1978-06-02 1979-05-25 Medical sleeve WO1980000007A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91201078A 1978-06-02 1978-06-02
US912010 1978-06-02

Publications (1)

Publication Number Publication Date
WO1980000007A1 true WO1980000007A1 (en) 1980-01-10

Family

ID=25431251

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1979/000354 WO1980000007A1 (en) 1978-06-02 1979-05-25 Medical sleeve

Country Status (4)

Country Link
US (2) US4501264A (en)
EP (1) EP0016047A1 (en)
IL (1) IL57559A (en)
WO (1) WO1980000007A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2497673A1 (en) * 1981-01-14 1982-07-16 Harboe Henrik DEVICE FOR REDUCING THE AVAILABLE VOLUME OF HUMAN STOMACH
US4416267A (en) * 1981-12-10 1983-11-22 Garren Lloyd R Method and apparatus for treating obesity
US4485805A (en) * 1982-08-24 1984-12-04 Gunther Pacific Limited Of Hong Kong Weight loss device and method
EP0137878A1 (en) * 1983-09-06 1985-04-24 Lloyd R. Garren Stomach insert for treating obesity
US5401241A (en) * 1992-05-07 1995-03-28 Inamed Development Co. Duodenal intubation catheter
WO2004041133A1 (en) * 2002-11-01 2004-05-21 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
FR2853829A1 (en) * 2003-04-16 2004-10-22 Cie Euro Etude Rech Paroscopie Intra-gastric implant insertion assembly includes sheath with opening edge fastened by releasable locking strip
US7037344B2 (en) 2002-11-01 2006-05-02 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
EP2164558A1 (en) * 2007-06-08 2010-03-24 Valentx, Inc. Methods and devices for intragastric support of functional or prosthetic gastrointestinal devices
US7892214B2 (en) 2002-11-01 2011-02-22 Valentx, Inc. Attachment system for transmural attachment at the gastroesophageal junction
US8956318B2 (en) 2012-05-31 2015-02-17 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9060844B2 (en) 2002-11-01 2015-06-23 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US9451960B2 (en) 2012-05-31 2016-09-27 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9675489B2 (en) 2012-05-31 2017-06-13 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9757264B2 (en) 2013-03-13 2017-09-12 Valentx, Inc. Devices and methods for gastrointestinal bypass

Families Citing this family (283)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4905693A (en) * 1983-10-03 1990-03-06 Biagio Ravo Surgical method for using an intraintestinal bypass graft
US4719916A (en) * 1983-10-03 1988-01-19 Biagio Ravo Intraintestinal bypass tube
US5104399A (en) 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US4592339A (en) * 1985-06-12 1986-06-03 Mentor Corporation Gastric banding device
JPS62236560A (en) * 1986-04-09 1987-10-16 テルモ株式会社 Catheter for repairing blood vessel
US4793348A (en) * 1986-11-15 1988-12-27 Palmaz Julio C Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation
US4762128A (en) * 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US5527336A (en) * 1986-12-09 1996-06-18 Boston Scientific Corporation Flow obstruction treatment method
US4893623A (en) * 1986-12-09 1990-01-16 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US5041126A (en) * 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US20040127969A1 (en) * 1987-04-06 2004-07-01 Lazarus Harrison M. Artificial graft and implantation method
US5133732A (en) 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US4909252A (en) * 1988-05-26 1990-03-20 The Regents Of The Univ. Of California Perfusion balloon catheter
US4925446A (en) * 1988-07-06 1990-05-15 Transpharm Group Inc. Removable inflatable intragastrointestinal device for delivering beneficial agents
US5007790A (en) * 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US6004261A (en) * 1989-04-28 1999-12-21 C. R. Bard, Inc. Formed-in-place endovascular stent and delivery system
US5100429A (en) * 1989-04-28 1992-03-31 C. R. Bard, Inc. Endovascular stent and delivery system
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US4994033A (en) * 1989-05-25 1991-02-19 Schneider (Usa) Inc. Intravascular drug delivery dilatation catheter
US5049131A (en) * 1989-05-31 1991-09-17 Ashridge Ag Balloon catheter
HU212760B (en) * 1989-06-20 1997-02-28 Denes Method and device for the apportion of chemical materials into the vein wall
EP0574378B1 (en) * 1989-06-28 1995-11-08 ZIMMON, David S. Balloon tamponade devices
US5622188A (en) * 1989-08-18 1997-04-22 Endovascular Instruments, Inc. Method of restoring reduced or absent blood flow capacity in an artery
US5571169A (en) * 1993-06-07 1996-11-05 Endovascular Instruments, Inc. Anti-stenotic method and product for occluded and partially occluded arteries
US6344053B1 (en) * 1993-12-22 2002-02-05 Medtronic Ave, Inc. Endovascular support device and method
US4984564A (en) * 1989-09-27 1991-01-15 Frank Yuen Surgical retractor device
US5108370A (en) * 1989-10-03 1992-04-28 Paul Walinsky Perfusion balloon catheter
US5269785A (en) * 1990-06-28 1993-12-14 Bonutti Peter M Apparatus and method for tissue removal
CA2202800A1 (en) * 1991-04-11 1992-10-12 Alec A. Piplani Endovascular graft having bifurcation and apparatus and method for deploying the same
US6682557B1 (en) * 1991-04-11 2004-01-27 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system and method
CA2074304C (en) * 1991-08-02 1996-11-26 Cyril J. Schweich, Jr. Drug delivery catheter
US6503277B2 (en) 1991-08-12 2003-01-07 Peter M. Bonutti Method of transplanting human body tissue
US5306300A (en) * 1992-09-22 1994-04-26 Berry H Lee Tubular digestive screen
US5382231A (en) * 1993-02-02 1995-01-17 Shlain; Leonard M. Method for transesophageal retraction of the stomach
WO1994021196A2 (en) * 1993-03-18 1994-09-29 C.R. Bard, Inc. Endovascular stents
NL9300500A (en) * 1993-03-22 1994-10-17 Industrial Res Bv Expandable hollow sleeve for locally supporting and / or strengthening a body vessel, as well as a method for manufacturing it.
WO1994023669A1 (en) * 1993-04-13 1994-10-27 Boston Scientific Corporation Prosthesis delivery system with dilating tip
WO1994023786A1 (en) * 1993-04-13 1994-10-27 Boston Scientific Corporation Prosthesis delivery system
US5985307A (en) * 1993-04-14 1999-11-16 Emory University Device and method for non-occlusive localized drug delivery
US5433706A (en) * 1993-10-25 1995-07-18 Cordis Corporation Perfusion balloon catheter
US5613948A (en) * 1993-11-12 1997-03-25 Cordis Corporation Annular perfusion balloon catheter
US6245040B1 (en) 1994-01-14 2001-06-12 Cordis Corporation Perfusion balloon brace and method of use
US5484411A (en) * 1994-01-14 1996-01-16 Cordis Corporation Spiral shaped perfusion balloon and method of use and manufacture
US5792300A (en) * 1994-01-21 1998-08-11 Cordis Corporation Perfusion catheter and striped extrusion method of manufacture
US5423851A (en) * 1994-03-06 1995-06-13 Samuels; Shaun L. W. Method and apparatus for affixing an endoluminal device to the walls of tubular structures within the body
US5501667A (en) * 1994-03-15 1996-03-26 Cordis Corporation Perfusion balloon and method of use and manufacture
US6001123A (en) * 1994-04-01 1999-12-14 Gore Enterprise Holdings Inc. Folding self-expandable intravascular stent-graft
US6165210A (en) * 1994-04-01 2000-12-26 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
CA2188563C (en) 1994-04-29 2005-08-02 Andrew W. Buirge Stent with collagen
US6331188B1 (en) 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US6818014B2 (en) * 1995-03-01 2004-11-16 Scimed Life Systems, Inc. Longitudinally flexible expandable stent
US7204848B1 (en) * 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
DE69622231T2 (en) 1995-03-01 2002-12-05 Scimed Life Systems Inc LENGTHFLEXIBLE AND EXPANDABLE STENT
US6896696B2 (en) 1998-11-20 2005-05-24 Scimed Life Systems, Inc. Flexible and expandable stent
US20070073384A1 (en) * 1995-03-01 2007-03-29 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US6981986B1 (en) 1995-03-01 2006-01-03 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US5707355A (en) * 1995-11-15 1998-01-13 Zimmon Science Corporation Apparatus and method for the treatment of esophageal varices and mucosal neoplasms
JP2000503559A (en) 1995-12-14 2000-03-28 ゴア エンタープライズ ホールディングス,インコーポレイティド Apparatus and method for deploying a stent-graft
US6042605A (en) * 1995-12-14 2000-03-28 Gore Enterprose Holdings, Inc. Kink resistant stent-graft
US6379391B1 (en) 1999-09-15 2002-04-30 Medidea, Llc Method and apparatus for positioning a prosthetic element relative to a bone to achieve a desired orientation
US5743852A (en) * 1996-04-15 1998-04-28 Johnson; William T. M. Speculums
US20040106985A1 (en) * 1996-04-26 2004-06-03 Jang G. David Intravascular stent
JP4636634B2 (en) * 1996-04-26 2011-02-23 ボストン サイエンティフィック サイムド,インコーポレイテッド Intravascular stent
US6241760B1 (en) * 1996-04-26 2001-06-05 G. David Jang Intravascular stent
US6235053B1 (en) * 1998-02-02 2001-05-22 G. David Jang Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors
US6152957A (en) * 1996-04-26 2000-11-28 Jang; G. David Intravascular stent
US5733326A (en) * 1996-05-28 1998-03-31 Cordis Corporation Composite material endoprosthesis
US6027528A (en) * 1996-05-28 2000-02-22 Cordis Corporation Composite material endoprosthesis
US5735831A (en) * 1996-07-10 1998-04-07 Cordis Corporation Expandable flowrate catheter assembly and method of making same
US6551350B1 (en) 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
US6352561B1 (en) 1996-12-23 2002-03-05 W. L. Gore & Associates Implant deployment apparatus
US5925061A (en) * 1997-01-13 1999-07-20 Gore Enterprise Holdings, Inc. Low profile vascular stent
GB9708568D0 (en) * 1997-04-29 1997-06-18 Smiths Industries Ltd Cuffed medico-surgical tubes
US5820584A (en) * 1997-08-28 1998-10-13 Crabb; Jerry A. Duodenal insert and method of use
US6251418B1 (en) * 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
US6197324B1 (en) 1997-12-18 2001-03-06 C. R. Bard, Inc. System and methods for local delivery of an agent
US6206913B1 (en) * 1998-08-12 2001-03-27 Vascular Innovations, Inc. Method and system for attaching a graft to a blood vessel
US6689121B1 (en) 1998-09-24 2004-02-10 C. R. Bard, Inc. Systems and methods for treating ischemia
US6458092B1 (en) 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
US6432126B1 (en) 1998-09-30 2002-08-13 C.R. Bard, Inc. Flexible vascular inducing implants
US6248112B1 (en) 1998-09-30 2001-06-19 C. R. Bard, Inc. Implant delivery system
US6692520B1 (en) 1998-12-15 2004-02-17 C. R. Bard, Inc. Systems and methods for imbedded intramuscular implants
US6986784B1 (en) 1999-05-14 2006-01-17 C. R. Bard, Inc. Implant anchor systems
US6855160B1 (en) 1999-08-04 2005-02-15 C. R. Bard, Inc. Implant and agent delivery device
US6689062B1 (en) 1999-11-23 2004-02-10 Microaccess Medical Systems, Inc. Method and apparatus for transesophageal cardiovascular procedures
US6729356B1 (en) 2000-04-27 2004-05-04 Endovascular Technologies, Inc. Endovascular graft for providing a seal with vasculature
AU6299401A (en) * 2000-05-08 2001-11-20 Qtl Biosystems Llc Improvements to the fluorescent polymer-qtl approach to biosensing
US7232421B1 (en) 2000-05-12 2007-06-19 C. R. Bard, Inc. Agent delivery systems
US7204847B1 (en) 2000-07-28 2007-04-17 C. R. Bard, Inc. Implant anchor systems
US20020116049A1 (en) * 2000-09-22 2002-08-22 Scimed Life Systems, Inc. Stent
US7766956B2 (en) * 2000-09-22 2010-08-03 Boston Scientific Scimed, Inc. Intravascular stent and assembly
US8070792B2 (en) 2000-09-22 2011-12-06 Boston Scientific Scimed, Inc. Stent
US7033373B2 (en) 2000-11-03 2006-04-25 Satiety, Inc. Method and device for use in minimally invasive placement of space-occupying intragastric devices
US6558400B2 (en) 2001-05-30 2003-05-06 Satiety, Inc. Obesity treatment tools and methods
US7083629B2 (en) * 2001-05-30 2006-08-01 Satiety, Inc. Overtube apparatus for insertion into a body
US6845776B2 (en) * 2001-08-27 2005-01-25 Richard S. Stack Satiation devices and methods
US20040117031A1 (en) * 2001-08-27 2004-06-17 Stack Richard S. Satiation devices and methods
CN101810521B (en) 2001-08-27 2015-05-13 辛尼科有限责任公司 Satiation devices and methods
US6675809B2 (en) * 2001-08-27 2004-01-13 Richard S. Stack Satiation devices and methods
US7097665B2 (en) 2003-01-16 2006-08-29 Synecor, Llc Positioning tools and methods for implanting medical devices
US20060292206A1 (en) 2001-11-26 2006-12-28 Kim Steven W Devices and methods for treatment of vascular aneurysms
US7239912B2 (en) 2002-03-22 2007-07-03 Leptos Biomedical, Inc. Electric modulation of sympathetic nervous system
US20030187498A1 (en) * 2002-03-28 2003-10-02 Medtronic Ave, Inc. Chamfered stent strut and method of making same
US7146984B2 (en) * 2002-04-08 2006-12-12 Synecor, Llc Method and apparatus for modifying the exit orifice of a satiation pouch
US6773440B2 (en) * 2002-07-02 2004-08-10 Satiety, Inc. Method and device for use in tissue approximation and fixation
US6746460B2 (en) * 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
US7211114B2 (en) 2002-08-26 2007-05-01 The Trustees Of Columbia University In The City Of New York Endoscopic gastric bypass
US6981978B2 (en) * 2002-08-30 2006-01-03 Satiety, Inc. Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach
US7033384B2 (en) * 2002-08-30 2006-04-25 Satiety, Inc. Stented anchoring of gastric space-occupying devices
US7214233B2 (en) * 2002-08-30 2007-05-08 Satiety, Inc. Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach
EP1542616B1 (en) 2002-09-20 2015-04-22 Endologix, Inc. Stent-graft with positioning anchor
US7220237B2 (en) * 2002-10-23 2007-05-22 Satiety, Inc. Method and device for use in endoscopic organ procedures
US7229428B2 (en) * 2002-10-23 2007-06-12 Satiety, Inc. Method and device for use in endoscopic organ procedures
US20090149871A9 (en) * 2002-11-01 2009-06-11 Jonathan Kagan Devices and methods for treating morbid obesity
US7794447B2 (en) * 2002-11-01 2010-09-14 Valentx, Inc. Gastrointestinal sleeve device and methods for treatment of morbid obesity
US7837669B2 (en) * 2002-11-01 2010-11-23 Valentx, Inc. Devices and methods for endolumenal gastrointestinal bypass
US20060015125A1 (en) * 2004-05-07 2006-01-19 Paul Swain Devices and methods for gastric surgery
US6656194B1 (en) * 2002-11-05 2003-12-02 Satiety, Inc. Magnetic anchoring devices
US7481821B2 (en) 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
US7695446B2 (en) * 2002-12-02 2010-04-13 Gi Dynamics, Inc. Methods of treatment using a bariatric sleeve
US20070032879A1 (en) * 2002-12-02 2007-02-08 Levine Andy H Anti-buckling sleeve
US7025791B2 (en) * 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
EP1569582B1 (en) 2002-12-02 2017-05-31 GI Dynamics, Inc. Bariatric sleeve
US7678068B2 (en) * 2002-12-02 2010-03-16 Gi Dynamics, Inc. Atraumatic delivery devices
US7608114B2 (en) 2002-12-02 2009-10-27 Gi Dynamics, Inc. Bariatric sleeve
US20040143342A1 (en) 2003-01-16 2004-07-22 Stack Richard S. Satiation pouches and methods of use
US20040260382A1 (en) 2003-02-12 2004-12-23 Fogarty Thomas J. Intravascular implants and methods of using the same
US7291160B2 (en) 2003-03-17 2007-11-06 Delegge Rebecca Intragastric catheter
US20040249362A1 (en) * 2003-03-28 2004-12-09 Gi Dynamics, Inc. Enzyme sleeve
GB0307367D0 (en) * 2003-03-29 2003-05-07 Twg Composition and method for treating the gastro-intestinal tract
EP1462116A1 (en) * 2003-03-29 2004-09-29 Villitech SARL Composition for treating the gastrointestinal tract
US7175638B2 (en) 2003-04-16 2007-02-13 Satiety, Inc. Method and devices for modifying the function of a body organ
US6846323B2 (en) 2003-05-15 2005-01-25 Advanced Cardiovascular Systems, Inc. Intravascular stent
US7731757B2 (en) * 2003-06-01 2010-06-08 Reflux Corporation Obesity treatment
US20050015110A1 (en) * 2003-07-18 2005-01-20 Fogarty Thomas J. Embolization device and a method of using the same
US20060079924A1 (en) * 2003-07-24 2006-04-13 Femspec Llc Apparatus for accessing a body cavity and methods of making same
US7314489B2 (en) * 2003-08-20 2008-01-01 Ethicon Endo-Surgery, Inc. Method and apparatus to facilitate nutritional malabsorption
ATE429192T1 (en) * 2003-09-24 2009-05-15 Wael Mohamed Nabil Lotfy LINED BALLOON-MOUNTED STENT
US20050247320A1 (en) * 2003-10-10 2005-11-10 Stack Richard S Devices and methods for retaining a gastro-esophageal implant
US8206456B2 (en) 2003-10-10 2012-06-26 Barosense, Inc. Restrictive and/or obstructive implant system for inducing weight loss
US7914543B2 (en) 2003-10-14 2011-03-29 Satiety, Inc. Single fold device for tissue fixation
US7097650B2 (en) * 2003-10-14 2006-08-29 Satiety, Inc. System for tissue approximation and fixation
US20050085787A1 (en) * 2003-10-17 2005-04-21 Laufer Michael D. Minimally invasive gastrointestinal bypass
EP1708655A1 (en) * 2003-12-09 2006-10-11 GI Dynamics, Inc. Apparatus to be anchored within the gastrointestinal tract and anchoring method
US8057420B2 (en) * 2003-12-09 2011-11-15 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
US20060212042A1 (en) * 2005-03-17 2006-09-21 Lamport Ronald B Removal and repositioning device
US20050177176A1 (en) * 2004-02-05 2005-08-11 Craig Gerbi Single-fold system for tissue approximation and fixation
EP1713402B1 (en) * 2004-02-13 2018-07-04 Ethicon Endo-Surgery, Inc. Device for reducing stomach volume
US7931693B2 (en) * 2004-02-26 2011-04-26 Endosphere, Inc. Method and apparatus for reducing obesity
US8585771B2 (en) * 2004-02-26 2013-11-19 Endosphere, Inc. Methods and devices to curb appetite and/or to reduce food intake
US8147561B2 (en) * 2004-02-26 2012-04-03 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
EP1725194B1 (en) * 2004-02-27 2018-01-17 Ethicon Endo-Surgery, Inc. Methods and devices for reducing stomach volume
US20050197714A1 (en) * 2004-03-02 2005-09-08 Sayet Peter H. System, system devices, and methods for regulating nutrient absorption and caloric intake
US9028511B2 (en) 2004-03-09 2015-05-12 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
US8449560B2 (en) 2004-03-09 2013-05-28 Satiety, Inc. Devices and methods for placement of partitions within a hollow body organ
US8628547B2 (en) 2004-03-09 2014-01-14 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
US8252009B2 (en) * 2004-03-09 2012-08-28 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
DE102004011764A1 (en) * 2004-03-09 2005-09-29 Novineon Healthcare Technology Partners Gmbh Medical implant
CA2561193A1 (en) 2004-03-26 2005-10-20 Satiety, Inc. Systems and methods for treating obesity
EP1740132B1 (en) 2004-04-26 2014-12-31 Synecor, LLC Restrictive and/or obstructive implant for inducing weight loss
WO2005107641A2 (en) * 2004-05-03 2005-11-17 Fulfillium, Inc. Method and system for gastric volume control
US7803195B2 (en) * 2004-06-03 2010-09-28 Mayo Foundation For Medical Education And Research Obesity treatment and device
US7837643B2 (en) * 2004-07-09 2010-11-23 Gi Dynamics, Inc. Methods and devices for placing a gastrointestinal sleeve
US20060020277A1 (en) * 2004-07-20 2006-01-26 Gostout Christopher J Gastric reshaping devices and methods
EP1778131B1 (en) * 2004-07-22 2012-01-11 Nellix, Inc. Systems for endovascular aneurysm treatment
US8048145B2 (en) 2004-07-22 2011-11-01 Endologix, Inc. Graft systems having filling structures supported by scaffolds and methods for their use
AU2005287010B2 (en) * 2004-09-17 2010-04-15 Gi Dynamics, Inc. Gastrointestinal anchor
US20070078476A1 (en) * 2004-10-12 2007-04-05 Hull Wendell C Sr Overweight control apparatuses for insertion into the stomach
US20060106288A1 (en) 2004-11-17 2006-05-18 Roth Alex T Remote tissue retraction device
US9456915B2 (en) 2004-11-19 2016-10-04 Fulfilium, Inc. Methods, devices, and systems for obesity treatment
US8070807B2 (en) 2004-11-19 2011-12-06 Fulfillium, Inc. Wireless breach detection
US7699863B2 (en) * 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7785291B2 (en) * 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US20060222596A1 (en) 2005-04-01 2006-10-05 Trivascular, Inc. Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
JP5070373B2 (en) 2005-04-28 2012-11-14 エンドーロジックス インコーポレイテッド Graft system having a filling structure supported by a framework and method of use thereof
US7976488B2 (en) 2005-06-08 2011-07-12 Gi Dynamics, Inc. Gastrointestinal anchor compliance
EP1903985A4 (en) 2005-07-07 2010-04-28 Nellix Inc Systems and methods for endovascular aneurysm treatment
US9055942B2 (en) * 2005-10-03 2015-06-16 Boston Scienctific Scimed, Inc. Endoscopic plication devices and methods
US20080190989A1 (en) * 2005-10-03 2008-08-14 Crews Samuel T Endoscopic plication device and method
EP1948280A4 (en) * 2005-10-24 2011-07-06 Andrew Young Biliary/pancreatic shunt device and method for treatment of metabolic and other diseases
US10603413B2 (en) * 2005-11-15 2020-03-31 Allen B. Kantrowitz Disintegrating digestive tract barrier
US20070150041A1 (en) * 2005-12-22 2007-06-28 Nellix, Inc. Methods and systems for aneurysm treatment using filling structures
US8376981B2 (en) * 2006-03-02 2013-02-19 Michael D. Laufer Gastrointestinal implant and methods for use
WO2007103773A2 (en) * 2006-03-02 2007-09-13 Laufer Michael D Gastrointestinal implant and methods for use
US20070219618A1 (en) * 2006-03-17 2007-09-20 Cully Edward H Endoprosthesis having multiple helically wound flexible framework elements
US20080228126A1 (en) * 2006-03-23 2008-09-18 The Trustees Of Columbia University In The City Of New York Method of inhibiting disruption of the healing process in a physically modified stomach
US7481836B2 (en) * 2006-03-30 2009-01-27 Medtronic Vascular, Inc. Prosthesis with coupling zone and methods
US7881797B2 (en) * 2006-04-25 2011-02-01 Valentx, Inc. Methods and devices for gastrointestinal stimulation
US7790273B2 (en) * 2006-05-24 2010-09-07 Nellix, Inc. Material for creating multi-layered films and methods for making the same
US9060835B2 (en) * 2006-05-26 2015-06-23 Endosphere, Inc. Conformationally-stabilized intraluminal device for medical applications
US7872068B2 (en) * 2006-05-30 2011-01-18 Incept Llc Materials formable in situ within a medical device
US20080109027A1 (en) * 2006-08-01 2008-05-08 Fulfillium, Inc. Method and system for gastric volume control
US8216297B2 (en) * 2006-08-14 2012-07-10 Trivascular, Inc. Dual chamber cuff structure
US20080065136A1 (en) * 2006-08-30 2008-03-13 Andrew Young Distender device and method for treatment of obesity and metabolic and other diseases
US8109895B2 (en) * 2006-09-02 2012-02-07 Barosense, Inc. Intestinal sleeves and associated deployment systems and methods
US7988720B2 (en) 2006-09-12 2011-08-02 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US20090125040A1 (en) * 2006-09-13 2009-05-14 Hambly Pablo R Tissue acquisition devices and methods
EP2068719B1 (en) 2006-09-15 2017-10-25 Boston Scientific Scimed, Inc. System for anchoring stomach implant
WO2008039800A2 (en) * 2006-09-25 2008-04-03 Valentx, Inc. Toposcopic access and delivery devices
US8801647B2 (en) * 2007-02-22 2014-08-12 Gi Dynamics, Inc. Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks
WO2008112894A1 (en) * 2007-03-15 2008-09-18 Jiayi Li Devices, systems, kits and methods for treatment of obesity
US9717584B2 (en) * 2007-04-13 2017-08-01 W. L. Gore & Associates, Inc. Medical apparatus and method of making the same
US9642693B2 (en) * 2007-04-13 2017-05-09 W. L. Gore & Associates, Inc. Medical apparatus and method of making the same
US20080255678A1 (en) * 2007-04-13 2008-10-16 Cully Edward H Medical apparatus and method of making the same
JP5331104B2 (en) * 2007-05-12 2013-10-30 バロセンス、インク Apparatus and method for gastric segmentation
US20090012544A1 (en) * 2007-06-08 2009-01-08 Valen Tx, Inc. Gastrointestinal bypass sleeve as an adjunct to bariatric surgery
EP2157919A4 (en) * 2007-06-11 2011-06-22 Valentx Inc Endoscopic delivery devices and methods
US20110137227A1 (en) * 2007-07-16 2011-06-09 Mckinley James T Methods and devices for delivering or delaying lipids within a duodenum
CA2696993C (en) 2007-07-18 2017-01-03 Samuel T. Crews Endoscopic implant system and method
US20090030284A1 (en) * 2007-07-18 2009-01-29 David Cole Overtube introducer for use in endoscopic bariatric surgery
WO2009036244A1 (en) * 2007-09-12 2009-03-19 Endometabolic Solutions, Inc. Devices and methods for treatment of obesity
US20090093839A1 (en) * 2007-10-04 2009-04-09 Brian Kelleher Devices and methods for augmenting extragastric banding
US20090171383A1 (en) 2007-12-31 2009-07-02 David Cole Gastric space occupier systems and methods of use
US7862538B2 (en) * 2008-02-04 2011-01-04 Incept Llc Surgical delivery system for medical sealant
US8020741B2 (en) 2008-03-18 2011-09-20 Barosense, Inc. Endoscopic stapling devices and methods
US20090248059A1 (en) * 2008-03-25 2009-10-01 Hesham Morsi Embolectomy Catheter
US8226593B2 (en) 2008-04-09 2012-07-24 E2 Llc Pyloric valve
US8100850B2 (en) * 2008-04-09 2012-01-24 E2 Llc Pyloric valve devices and methods
US20090259246A1 (en) * 2008-04-14 2009-10-15 Sherif Eskaros Intragastric Volume-Occupying Device
AU2009240419A1 (en) 2008-04-25 2009-10-29 Nellix, Inc. Stent graft delivery system
CA2726596A1 (en) 2008-06-04 2009-12-10 Nellix, Inc. Sealing apparatus and methods of use
AU2009262832A1 (en) * 2008-06-04 2009-12-30 Nellix, Inc. Docking apparatus and methods of use
US8771170B2 (en) * 2008-08-01 2014-07-08 Microaccess, Inc. Methods and apparatus for transesophageal microaccess surgery
US8357118B2 (en) * 2008-08-26 2013-01-22 Cook Medical Technologies Llc Balloon catheters having a plurality of needles for the injection of one or more therapeutic agents
WO2010029190A1 (en) * 2008-09-15 2010-03-18 Joensson Anders Medical device, method and system for temporary occlusion of an opening in a lumen of a body
US7934631B2 (en) 2008-11-10 2011-05-03 Barosense, Inc. Multi-fire stapling systems and methods for delivering arrays of staples
US20100268297A1 (en) * 2009-02-24 2010-10-21 Hans Neisz Duodenal Stimulation To Induce Satiety
US20100228337A1 (en) * 2009-03-04 2010-09-09 Abbott Laboratories Vascular Enterprises Limited Mirror image stent and method of use
US8702641B2 (en) 2009-04-03 2014-04-22 Metamodix, Inc. Gastrointestinal prostheses having partial bypass configurations
US8211186B2 (en) 2009-04-03 2012-07-03 Metamodix, Inc. Modular gastrointestinal prostheses
US9173760B2 (en) 2009-04-03 2015-11-03 Metamodix, Inc. Delivery devices and methods for gastrointestinal implants
US20120065571A1 (en) * 2009-04-03 2012-03-15 Metamodix, Inc. Expandable pyloric anchors and methods for securing intestinal bypass sleeves
US9278019B2 (en) 2009-04-03 2016-03-08 Metamodix, Inc Anchors and methods for intestinal bypass sleeves
US8321030B2 (en) 2009-04-20 2012-11-27 Advanced Neuromodulation Systems, Inc. Esophageal activity modulated obesity therapy
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
WO2010127305A2 (en) 2009-05-01 2010-11-04 Endologix, Inc. Percutaneous method and device to treat dissections
US20100276469A1 (en) * 2009-05-01 2010-11-04 Barosense, Inc. Plication tagging device and method
US8961539B2 (en) 2009-05-04 2015-02-24 Boston Scientific Scimed, Inc. Endoscopic implant system and method
US8340772B2 (en) 2009-05-08 2012-12-25 Advanced Neuromodulation Systems, Inc. Brown adipose tissue utilization through neuromodulation
CN102470038A (en) 2009-07-10 2012-05-23 美特默迪克斯公司 External anchoring configurations for modular gastrointestinal prostheses
EP2459127B1 (en) 2009-07-27 2015-09-23 Endologix, Inc. Stent graft
WO2011044486A1 (en) * 2009-10-09 2011-04-14 Boston Scientific Scimed, Inc. Stomach bypass for the treatment of obesity
US20110276078A1 (en) 2009-12-30 2011-11-10 Nellix, Inc. Filling structure for a graft system and methods of use
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
WO2012047939A2 (en) * 2010-10-04 2012-04-12 Ind Platforms Llc Expandable devices, rail systems, and motorized devices
US9962275B2 (en) 2010-10-07 2018-05-08 Randy Louis Werneth Temporary gastric device (TGD) and method of use
US9393100B2 (en) 2010-11-17 2016-07-19 Endologix, Inc. Devices and methods to treat vascular dissections
US8963708B2 (en) 2011-01-13 2015-02-24 Sensurtec, Inc. Breach detection in solid structures
US8801768B2 (en) 2011-01-21 2014-08-12 Endologix, Inc. Graft systems having semi-permeable filling structures and methods for their use
US8790388B2 (en) 2011-03-03 2014-07-29 Boston Scientific Scimed, Inc. Stent with reduced profile
EP2680797B1 (en) 2011-03-03 2016-10-26 Boston Scientific Scimed, Inc. Low strain high strength stent
CN103648437B (en) 2011-04-06 2016-05-04 恩朵罗杰克斯国际控股有限公司 For the method and system of vascular aneurysms treatment
US8636810B2 (en) 2011-09-28 2014-01-28 Ethicon, Inc. Negative pressure intestinal anastomosis protection devices
CA3081285C (en) 2012-05-14 2022-05-31 C.R. Bard, Inc. Uniformly expandable stent
US9358022B2 (en) 2012-05-21 2016-06-07 Noha, Llc Clot removal device and method of using same
CN104334123B (en) 2012-06-07 2019-02-12 意比图密医疗有限公司 Expansion device
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food
WO2014113483A1 (en) 2013-01-15 2014-07-24 Metamodix, Inc. System and method for affecting intestinal microbial flora
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
WO2014159093A1 (en) 2013-03-14 2014-10-02 Endologix, Inc. Method for forming materials in situ within a medical device
US11129793B2 (en) 2013-12-05 2021-09-28 Epitomee Medical Ltd Retentive devices and systems for in-situ release of pharmaceutical active agents
US20150223956A1 (en) * 2014-02-12 2015-08-13 Children's National Medical Center Anchored non-spherical balloon for the treatment of obesity
US10123896B2 (en) 2014-03-06 2018-11-13 Mayo Foundation For Medical Education And Research Apparatus and methods of inducing weight loss using blood flow control
CN107072652B (en) * 2014-06-18 2019-08-02 哈佛学院院长及董事 Soft retractor
WO2015200554A1 (en) 2014-06-26 2015-12-30 Boston Scientific Scimed, Inc. Medical devices and methods to prevent bile reflux after bariatric procedures
EP3193780A1 (en) 2014-09-18 2017-07-26 Boston Scientific Scimed Inc. Device allowing pyloric sphincter to normally function for bariatric stents
US10226599B2 (en) * 2014-12-23 2019-03-12 C.R. Bard, Inc. Inflatable medical device and related sheath
WO2017048989A1 (en) * 2015-09-15 2017-03-23 Fong Kenton D Devices and methods for anchoring a sheath in a tissue cavity
US9622897B1 (en) 2016-03-03 2017-04-18 Metamodix, Inc. Pyloric anchors and methods for intestinal bypass sleeves
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
US10751209B2 (en) 2016-05-19 2020-08-25 Metamodix, Inc. Pyloric anchor retrieval tools and methods
US10588769B2 (en) 2016-10-12 2020-03-17 Ethicon, Inc. Caloric bypass device
US10548753B2 (en) 2017-01-13 2020-02-04 Ethicon, Inc. Passive caloric bypass device
US10765546B2 (en) 2017-01-25 2020-09-08 Ethicon, Inc. Modified apparatus for food extraction and obesity treatment
US10575973B2 (en) 2018-04-11 2020-03-03 Abbott Cardiovascular Systems Inc. Intravascular stent having high fatigue performance

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3045677A (en) * 1960-05-03 1962-07-24 American Cystoscope Makers Inc Inflatable balloon catheter
US3046988A (en) * 1958-12-01 1962-07-31 Davol Rubber Co Esophageal nasogastric tube
US3991767A (en) * 1973-11-02 1976-11-16 Cutter Laboratories, Inc. Tubular unit with vessel engaging cuff structure
US4133315A (en) * 1976-12-27 1979-01-09 Berman Edward J Method and apparatus for reducing obesity
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4141364A (en) * 1977-03-18 1979-02-27 Jorge Schultze Expandable endotracheal or urethral tube

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3834394A (en) * 1969-11-21 1974-09-10 R Sessions Occlusion device and method and apparatus for inserting the same
US3863639A (en) * 1974-04-04 1975-02-04 Richard N Kleaveland Disposable visceral retainer
US4085757A (en) * 1976-04-29 1978-04-25 P Pevsner Miniature balloon catheter method and apparatus
US4134405A (en) * 1977-01-10 1979-01-16 Smit Julie A Catheter and intestine tube and method of using the same
US4246893A (en) * 1978-07-05 1981-01-27 Daniel Berson Inflatable gastric device for treating obesity
US4364392A (en) * 1980-12-04 1982-12-21 Wisconsin Alumni Research Foundation Detachable balloon catheter
US4416267A (en) * 1981-12-10 1983-11-22 Garren Lloyd R Method and apparatus for treating obesity
US4515587A (en) * 1983-02-14 1985-05-07 Smec, Inc. IAB having apparatus for assuring proper balloon inflation and deflation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3046988A (en) * 1958-12-01 1962-07-31 Davol Rubber Co Esophageal nasogastric tube
US3045677A (en) * 1960-05-03 1962-07-24 American Cystoscope Makers Inc Inflatable balloon catheter
US3991767A (en) * 1973-11-02 1976-11-16 Cutter Laboratories, Inc. Tubular unit with vessel engaging cuff structure
US4133315A (en) * 1976-12-27 1979-01-09 Berman Edward J Method and apparatus for reducing obesity
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4141364A (en) * 1977-03-18 1979-02-27 Jorge Schultze Expandable endotracheal or urethral tube

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2497673A1 (en) * 1981-01-14 1982-07-16 Harboe Henrik DEVICE FOR REDUCING THE AVAILABLE VOLUME OF HUMAN STOMACH
US4416267A (en) * 1981-12-10 1983-11-22 Garren Lloyd R Method and apparatus for treating obesity
US4899747A (en) * 1981-12-10 1990-02-13 Garren Lloyd R Method and appartus for treating obesity
US4485805A (en) * 1982-08-24 1984-12-04 Gunther Pacific Limited Of Hong Kong Weight loss device and method
EP0137878A1 (en) * 1983-09-06 1985-04-24 Lloyd R. Garren Stomach insert for treating obesity
US5401241A (en) * 1992-05-07 1995-03-28 Inamed Development Co. Duodenal intubation catheter
US9060844B2 (en) 2002-11-01 2015-06-23 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US8182459B2 (en) 2002-11-01 2012-05-22 Valentx, Inc. Devices and methods for endolumenal gastrointestinal bypass
WO2004041133A1 (en) * 2002-11-01 2004-05-21 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US9839546B2 (en) 2002-11-01 2017-12-12 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US7037344B2 (en) 2002-11-01 2006-05-02 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US7220284B2 (en) * 2002-11-01 2007-05-22 Valentx, Inc. Gastrointestinal sleeve device and methods for treatment of morbid obesity
US8968270B2 (en) 2002-11-01 2015-03-03 Valentx, Inc. Methods of replacing a gastrointestinal bypass sleeve for therapy adjustment
US10350101B2 (en) 2002-11-01 2019-07-16 Valentx, Inc. Devices and methods for endolumenal gastrointestinal bypass
US7892214B2 (en) 2002-11-01 2011-02-22 Valentx, Inc. Attachment system for transmural attachment at the gastroesophageal junction
US8012140B1 (en) 2002-11-01 2011-09-06 Valentx, Inc. Methods of transmural attachment in the gastrointestinal system
US9561127B2 (en) 2002-11-01 2017-02-07 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
FR2853829A1 (en) * 2003-04-16 2004-10-22 Cie Euro Etude Rech Paroscopie Intra-gastric implant insertion assembly includes sheath with opening edge fastened by releasable locking strip
WO2004093753A3 (en) * 2003-04-16 2005-01-06 Cie Euro Etude Rech Paroscopie Kit for the insertion of an intragastric implant, case for inserting such an implant, and corresponding production method
WO2004093753A2 (en) * 2003-04-16 2004-11-04 Compagnie Europeenne D'etude Et De Recherche De Dispositifs Pour L'implantation Par Laparoscopie Kit for the insertion of an intragastric implant, case for inserting such an implant, and corresponding production method
EP2164558A4 (en) * 2007-06-08 2010-08-04 Valentx Inc Methods and devices for intragastric support of functional or prosthetic gastrointestinal devices
EP2164558A1 (en) * 2007-06-08 2010-03-24 Valentx, Inc. Methods and devices for intragastric support of functional or prosthetic gastrointestinal devices
US9039649B2 (en) 2012-05-31 2015-05-26 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9451960B2 (en) 2012-05-31 2016-09-27 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9173759B2 (en) 2012-05-31 2015-11-03 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9566181B2 (en) 2012-05-31 2017-02-14 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9675489B2 (en) 2012-05-31 2017-06-13 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9681975B2 (en) 2012-05-31 2017-06-20 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9050168B2 (en) 2012-05-31 2015-06-09 Valentx, Inc. Devices and methods for gastrointestinal bypass
US8956318B2 (en) 2012-05-31 2015-02-17 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9757264B2 (en) 2013-03-13 2017-09-12 Valentx, Inc. Devices and methods for gastrointestinal bypass

Also Published As

Publication number Publication date
US4641653A (en) 1987-02-10
IL57559A (en) 1984-06-29
US4501264A (en) 1985-02-26
EP0016047A1 (en) 1980-10-01

Similar Documents

Publication Publication Date Title
US4501264A (en) Medical sleeve
US4763653A (en) Medical sleeve
US7033384B2 (en) Stented anchoring of gastric space-occupying devices
US9326879B2 (en) Systems and methods for bariatric therapy
EP2699199B1 (en) System for bariatric therapy
EP1214020B2 (en) Prosthesis for abdominal aortic aneurysm repair
US8114045B2 (en) Apparatus and methods for delaying gastric emptying to treat obesity
US4899747A (en) Method and appartus for treating obesity
US4416267A (en) Method and apparatus for treating obesity
US8870806B2 (en) Methods of treatment using a bariatric sleeve
EP3490465B1 (en) Stent with one-way sock valve
US20090093839A1 (en) Devices and methods for augmenting extragastric banding
EP2760383B1 (en) Negative pressure intestinal anastomosis protection devices
US20070265709A1 (en) Gastric Bypass Devices and Methods
WO2004017863A2 (en) Endoscopic gastric bypass
US20180228632A1 (en) Devices and Methods for Anchoring an Endoluminal Sleeve in the GI Tract
WO2013023676A1 (en) Devices for anchoring an endoluminal sleeve in the gi tract
US20200276040A1 (en) Applicator and a method for the transpyloric placement or removal of a transpyloric and/or a transduodenal bypass device in/from the region of the pylorus of a patient

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): BR CH DE DK GB JP SE SU

Designated state(s): BR CH DE DK GB JP SE SU

AL Designated countries for regional patents

Designated state(s): FR

Kind code of ref document: A1

Designated state(s): FR